N-ε13-biotinyl-TP/Fl-streptavidin, 125I-TP |
fluorescence microscopy, gamma-counting |
visualization in the fixated Bowes cells [20,36]; cellular internalization of TP is not an artefact caused by cell fixation |
biotinyl-, Fl-, Abz-TP, -TP10 |
fluorescence microscopy, Transwell |
visualization of crossing a Caco-2 human colon cancer cell layer in vitro by a transcellular pathway [118] |
Fl-transportan antisense conjugates |
confocal microscopy |
mainly endocytic, macropinocytotic pathway for cellular uptake [46] |
TP |
FACS, spectrofluorimetry |
protein uptake by endocytotic mechanism in HeLa cells of CPP-avidin complexes [73] |
Fl-TP, -TP10 |
fluorescence microscopy, spectrofluorometry and FACS |
visualization in different mammalian and plant cells [119] |
TP |
FACS |
similar kinetic uptake profiles in HeLa, A549 and CHO cell lines [68] |
111In- or 68Ga-TP |
micro-PET imaging |
uptake by six tumor cell lines and biodistribution in PC-3 tumor-bearing nude mice [120] |
TP |
fluorescence polarization, quenching and CD spectroscopy |
in small phospholipid vesicles the helical penetratin and transportan lie along the vesicle surface, penetratin variants appear to penetrate deeper into the membrane [121] |
AU NP-functionalized TP- and TP10-protein |
TEM |
cell entry mechanisms and intracellular trafficking of constructs were studied [122] |
myristoylated TP-Tf |
fluorescence images and functional gene silencing by siRNA |
targeting of siRNA over BBB [99] |
TAMRA-TP10 |
fluorescence microscopy, cell toxicity |
complexes of with cisplatin (cPt) in (HEK293, HEL299, HeLa OS143B cell lines were visualized [123] |
Alexa488-TP10 |
flow cytometry, live-cell imaging and image analysis |
showed that the glycine-phenylalanine switch was most dramatic in TP10 [79] |
125I-TP10 and -TP10-2 |
in vivo injection |
BBB delivery [124] |
TP10 |
spheroid model of the BBB, ex vivo imaging |
showed increased delivery to mouse brains [125] |
TP- isoniazid |
Langmuir balance technique and AFM imaging |
conjugates showed similar internalization rate into EBC-1 human squamous cell carcinoma in imaging of penetrated lipid layers [126] |
Structure and interactions of transportan
|
TP |
CD |
random coil structure in water, in SDS micelles 60% induced helix [127] |
TP |
CD |
60% alpha-helix in phospholipid vesicles [128] |
TP |
CD |
helical structure in small phospholipid vesicles [121] |
TP |
NMR |
in neutral bicelles alpha-helix in the C-terminus and tendency to form an alpha-helix in the N-terminus [129] |
TP |
CD |
structure in neutral DMPC bicelles and negative DMPG-containing bicelles different from each other [130] |
TP |
CD |
obtain amphiphilic α-helix when bound to membranes of vesicles composed of typical eukaryotic lipids [131] |
TP10 |
solid-state 19F-NMR, CD |
a range of conformations in the DMPC/DMPG vesicle membrane-bound state, C-terminal α-helix is embedded in the membrane being tilted [132] |
TP10 and 5 analogs |
molecular dynamics simulation |
forming α-helical conformation, the higher membrane disturbance yields higher cellular uptake in cells [133] |
TP |
CD |
increased membrane affinity with DPPC and DPPC + mycolic acid mixed monolayers [126] |
TP10 |
Gibbs energy studies |
peptide-induced efflux, becoming faster with decrease of the Gibbs energies for binding and insertion [134] |
TP and analogs |
PepLook algorithm |
peptide polymorphism showed common conformational polymorphic characteristics [135] |
Cys-TP |
EPR |
in DMPC/cholesterol caused lipid ordering and a large increase in permeation [136] |
TP10 |
molecular dynamics |
interactions with POPC bilayer initiated α-helix with hydrophobic side facing the hydrophobic lipid core [137] |
TP10 |
confocal microscopy |
interaction of GPMVs revealed association with liquid-disordered membrane areas [138] |
PF6 |
DLS |
mean diameter of PF6/siRNA NPs was shown to be below 200 nm [27] |
PF14 |
DLS |
PF14/SCO NPs possessed a net negative charge [28] |
PFs |
CD, DLS, QSAR |
PFs/Luc-plasmid NPs for study of structural requirements for cell penetration [95] |
His-PFs, PF132 |
DLS, CD, calcein leakage |
complexes formed were small at pH 7 and grew under acidic conditions [96] |
Parallel mechanisms of endocytosis and direct translocation in cells
|
biotinyl-TP |
fluorescence microscopy |
cellular uptake by unrelated mechanisms [139] |
TP, TP10 |
Transwell model |
translocation across a Caco-2 human colon cancer cell layer by transcellular pathway [118] |
TP |
CRM and AFM |
entered SK-Mel-2 cells within 5 min and widespread distribution via a nonendocytic mechanism [140] |
TP, TP10 |
confocal laser scanning microscopy, GMPV |
showed the interactions with glycosaminoglycans [141] |
TP, TP10 |
fluorescence microscopy |
uptake, when conjugated to cargoes, involved both endocytosis and direct translocation [20,70] |
Biotinyl-TP, -TP10/avidin |
fluorescence microscopy |
cellular internalization in HeLa and Bowes cellc by endocytosis with different pathways [142] |
biotinyl-TP, -TP10/avidin |
confocal microscopy |
entered Cos-7 cells by caveolin-dependent endocytosis [72] |
biotinyl-TP, -TP10/avidin |
confocal microscopy |
entered HeLa cells via caveolin-1-dependent pathway [122] |
biotinyl-TP, -TP10/avidin |
FACS analysis and spectrofluorimetry |
clathrin-dependent and -independent endocytosis uptake in HeLa cells with partial depolarization [73] |
TP-PNA |
fluorescence microscopy |
rapid cellular uptake by non-receptor-dependent endocytosis [143] |
TP-PNA |
splice correction assay |
splice correction in HeLa/Luc cells with mainly endocytotic, particular macropinocytotic mechanism [46] |
TP-, TP10-PNA |
splice correction assay |
showed cellular translocation by endocytosis [47] |
TP/NPs, /BSA, /dextran |
fluorescence microscopy |
complexed with NPs showed in vitro and ex vivo cell entry via a receptor-dependent macropinocytosis process [144] |
Mechanisms of PepFects and NickFects
|
PF3, PF6 |
interaction studies with lipid membranes |
increased amphipathicity and their ability to insert into a lipid monolayer composed of zwitterionic phospholipids [145] |
NFs/pDNA |
membrane perturbation study |
pDNA cargo inhibited membrane perturbation by NFs [114] |
PF32/pDNA |
Transwell model |
uptake by brain endothelial cells via LRP-1 receptor-mediated endocytosis and scavenger receptors [146] |
PF14/SCO |
fluorescence microscopy |
SR-A3 and SR-A5 recruited by PF14/SCO complexes [147] |
PF14/Cy5-siRNA |
FCS, FCCS |
coexistence of monomers, self-aggregates of peptide/ON in complexes in solution and at the plasma membrane of live cells [148] |
NF1/, NF51/pDNA |
analysis of separated endosomal vesicles by differential centrifugation |
NF51 facilitates rapid internalization of complexes into the cells, NF1 is less capable to induce endosomal release [149] |
Delivery of the cargo
|
TP-BSA |
toxicity study |
showed no toxicity or initiation of an immune response in epithelial cells [78] |
TP6, TP7-PNA |
toxicity study |
significant cellular toxicity above 3−5 μM in TP-PNA conjugates [49] |
St-TP10/SCO |
splice-correcting assay, toxicity study |
delivery of SCOs for functional splice correction with no toxicity [92] |
St-TP10/plasmid |
toxicity study, gene expression in vivo |
entered different cells with high gene expression level with no toxicity and no nonimmunogenecity in vivo [60] |
TK- and TH- camptothecin |
toxicity study |
TH-camptothecin showed cytotoxicity to cancer cells [150] |
TP10, PFs/plasmid, /siRNA |
toxicity study |
peptide/plasmid and /siRNA showed no cytotoxic and immunogenic response, in vitro and in vivo [151] |
TP, TP10, TP-biot1, TP-biot13, TP10-biot1 |
toxicity study |
no significant cytotoxic effect at 0.5–5 µM [75] |
T9(dR)/siRNA |
cells, in vivo toxicity |
showed cellular delivery of siRNA and in mice infected with PR8 influenza virus, and antiviral activity [57] |
chloroquine-TP10 |
antimalarial activity |
higher antiplasmodial activity in safe delivery of antimalarial aminoquinolines [152] |
TP10-ciprofloxacin or -levofloxacin |
antifungal in vitro activity |
TP10-ciprofloxacin or -levofloxacin showed antifungal in vitro activity against human pathogenic yeasts [153] |